World | Business

GlaxoSmithKline Embroiled In Bribery Scandal In China

NPR | July 22, 2013 6:02 p.m.

GlaxoSmithKline officials have admitted that some of the pharmaceutical company’s top executives in China may have violated Chinese laws. Beijing has accused the company of engaging in a wide-ranging bribery scheme to boost sales and profits in the country. The company said it is cooperating with the investigation. Jim Zarroli


blog comments powered by Disqus
Thanks to our Sponsors:
become a sponsor
Thanks to our Sponsors
become a sponsor